23Aug/13

Astellas Pharma launches Astagraf XL in US markets – pharmabiz.com

Astellas Pharma launches Astagraf XL in US markets
pharmabiz.com
The recommended starting dose of Astagraf XL with basiliximab induction is 0.15 mg/kg once-daily. The recommended starting dose of Astagraf XL without basiliximab induction is 0.1 mg/kg once-daily (pre-operative) and 0.2 mg/kg once-daily (post
Astellas’ Astagraf XL Launched in U.S. – Analyst BlogNASDAQ
Astellas Pharma launches once-daily oral tacrolimus formulation in USPharmaceutical Business Review

all 5 news articles »